Chanelle Pharma, Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health, has announced the appointment of Pat McLoughlin as its new general manager.
McLoughlin has over two decades of experience in senior leadership roles at organisations including B. Braun & GlaxoSmithKline. His experience includes leading global manufacturing sites, spearheading major business transformations, and advancing safety and compliance standards. In his new role, he will oversee all operations across manufacturing, engineering, OPEX, supply chain, quality control and facilities.
Chief executive Angelo Gatto said: “Pat’s outstanding leadership and proven track record in operational excellence will be key to accelerating Chanelle Pharma’s growth and transformation. We are thrilled to welcome him to the team and look forward to his leadership in shaping the future of our operations.”
McLoughlin added: “I am excited to join Chanelle Pharma at such a pivotal time in its journey. The company’s commitment to innovation and its dedication to delivering high-quality products globally is truly inspiring. I look forward to working with the talented team to build on this legacy and drive continued success.”
